Quantum BioPharma (NASDAQ: QNTM) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and ...

In addition, Sunshine Biopharma is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and (ii) PLpro ...

Aspen Biopharma has been hit with an FDA warning letter outlining multiple issues at the company’s production facility in the Indian city of Hyderabad, including poor building design that could ...

Biopharma Dealmakers is a print and digital publication that showcases active partnering companies and their opportunities across the biopharma industry. Each issue focuses on up to four ...

Toronto, Ontario--(Newsfile Corp. - April 18, 2025) - Quantum BioPharma Ltd. (QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of ...

For more information on Quantum BioPharma, please visit www.quantumbiopharma.com. Forward-Looking Information This press release contains certain "forward-looking statements" within the meaning of ...